Shares: 30
Projected annual dividend income: £24 (this purchase) and £121.60 (entire holding)
That's right folks. Another GSK buy in July. So far 100% of my investing funds has gone to the pharmaceutical giant.
In fact, such is the GSK buying frenzy here it now composes nearly a third of my entire portfolio (see current breakdown below and--for a more up-to-date portfolio weighting--visit my Holdings page).
I am rather surprised to find myself tucking away so much of my funds in GSKs direction. indeed, the money had already pretty much been earmarked for one of a number of other investing avenues including a potential new portfolio addition (possibly BAE Systems, Marston's or Old Mutual) or top up (such as SSE or HSBC).
